Dr Richard Burt is an honorary consultant haematologist and senior clinical lecturer at UCLH and Imperial College London. He was awarded his medical degree at the University of Otago in New Zealand and his specialist medical training at the Royal Free Hospital, UCLH and Great Ormond Street Hospital. He undertook a CRUK PhD fellowship in Professor Adele Fielding’s laboratory at UCL, studying the role of the microenvironment in treatment resistance in acute lymphoblastic leukaemia. He was then awarded a post-doctoral Francis Crick fellowship and a CRUK Clinician Scientist fellowship to continue his research on the leukaemia microenvironment, focusing on the role of metabolic dependencies in the treatment resistant population. He was then awarded a clinical senior lecturer position at Imperial College in 2024 to establish his own laboratory there. Both his clinical and research interests focus on acute leukaemia, including ALL and AML.

Dr Tholouli completed her haematology training in Manchester, undertook a PhD at Manchester University investigating prognostic molecular markers in AML and consolidated her transplant experience at the Fred Hutchinson Cancer Centre, Seattle-USA, one of the world’s largest transplant centres. Her expertise covers a wide range of haemato-oncological malignancies (leukaemia, myeloma, lymphoma) and non-malignant disorders (bone marrow failures, aplastic anaemia). She is the Director of the Adult Stem Cell and Immunotherapy Unit. She is a member of the AML steering group and has authored many publications (manuscripts, book chapters) and presented at scientific congresses.